Author | Holly E. Rawizza, MD

Articles

Pharmacokinetic Interactions Between Ritonavir-Boosted Darunavir and NNRTIs: A Report of 3 Cases

September 01, 2008

Management of treatment-experienced patients with multidrug resistance can be challenging. Fortunately, since 2006, 4 new antiretroviral agents-darunavir, maraviroc, raltegravir, and etravirine-with activity against drug-resistant HIV have been approved.